Canada· CA-DIN-02229524
NORFLOXACIN
A norfloxacin product containing norfloxacin, registered in Canada by AA PHARMA INC. The same ATC class is registered in 11 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Norfloxacin is registered in 11 of 19 countries.
Countries holding a registration under ATC J01MA06 (norfloxacin), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 6 of them publish a price we can compare per daily dose
Norfloxacin · ATC J01MA06
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Finlandprice
- Germany
- Italyprice
- Japan
- Netherlands
- Polandprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of norfloxacin costs, country by country.
Normalised to the WHO defined daily dose (0.8 g), the median price runs from $0.65 in Italy to $3.00 in Switzerland — a ×4.6 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Norfloxacin · price per daily dose (0.8 g)
USD · FX 28 Sept 2026
- CH Switzerland$3.00
- IT Italy$0.65
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- NORFLOXACIN
- Manufacturer
- AA PHARMA INC
- Country
- Canada (CA)
- ATC code
- J01MA06
- ATC class
- Norfloxacin
- Defined daily dose
- 0.8 g, O
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
467 interactions on record for norfloxacin.
Graded by severity as the source publishes them — 86 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Norfloxacin · interactions on record
467 records
- 86 severe
- 219 moderate
- 51 minor
- 42 info
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- PrednisoloneA07EA01severe
69 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Norfloxacin in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomNorfloxacin 400mg tabletsWaymade Healthcare Plc
- SwitzerlandNorsol, FilmtablettenSandoz Pharmaceuticals AG
- SpainNORFLOXACINO LESVI 400 MG COMPRIMIDOS EFGLaboratorios Lesvi Sl
- PolandChibroxinLaboratoires Thea
- FinlandFloxanorratiopharm Oy
- CzechiaGYRABLOCKMedochemie Ltd., Limassol
- FranceCHIBROXINE 0,3 POUR CENT, collyre en solutionTHEA
- GermanyNorfloxaStada Arzneimittel Ag
Authorised across Europe · EMA
The same active substance is authorised in 21 EEA countries. Names it is sold under:
- Austria · Floxacin Stada, Norfloxacin Sandoz
- Bulgaria · Нолицин
- Cyprus · Gyrablock, Trizolin
- Czechia · Gyrablock, Nolicin
- Germany · Norfloxa, Norfloxacin 1 A Pharma
- Estonia · Nolicin
- Spain · Chibroxin, Norfloxacino Cinfa
- France · Chibroxine, Norfloxacine Biogaran
- Greece · Fluseminal, Norocin
- Croatia · Noflox, Nolicin
- Hungary · Nolicin, Nolicin-S
- Italy · Naflox, Norfloxacina Abc
- Lithuania · Nolicin
- Latvia · Nolicin, Norflox
- Malta · Norfloxacin Helcor
- Netherlands · Norfloxacine Cf, Norfloxacine Sandoz
- Poland · Chibroxin, Nolicin
- Portugal · Chibroxol, Norfloxacina Vitória
- Romania · Nolicin, Norfloxacin Helcor
- Slovenia · Nolicin
- Slovakia · Gyrablock, Nolicin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8bb8141e-8a56-447d-a715-087067ef50ea GET /v1/drugs/8bb8141e-8a56-447d-a715-087067ef50ea?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02229524",
"form": "TABLET",
"class": "Human",
"routes": [
"ORAL"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "J01MA06",
"schedule": [
"Prescription"
],
"drug_code": "47429",
"strengths": [
"400 MG"
],
"ahfs_class": null,
"substances": [
"NORFLOXACIN"
],
"product_categorization": null
}See everything about norfloxacin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.